7 -2 (88) 2026 - Pulatov U.S., Shopulotov Sh.A. - DIAGNOSTIC FEATURES OF REACTIVE ARTHRITIS OF UROGENITAL ETIOLOGY

DIAGNOSTIC FEATURES OF REACTIVE ARTHRITIS OF UROGENITAL ETIOLOGY

Pulatov U.S. - Samarkand State Medical University

Shopulotov Sh.A. - Head of the Quality Control and Emergency Medical Care Monitoring Department, Samarkand Branch of the Republican Center of Emergency Medical Care

Resume

Reactive arthritis of urogenital etiology presents significant diagnostic challenges due to the lack of specific diagnostic criteria and the variability of clinical manifestations. Chlamydia trachomatis, which initiates an immune-mediated inflammatory process in the joints, is considered the leading etiologic factor. The aim of this study was to evaluate modern clinical, laboratory, and molecular genetic methods for diagnosing reactive arthritis. A prospective study of 50 patients in the study group and 50 individuals in the control group was conducted using clinical, microbiological, immunological, and genetic methods (HLA-B27, IL-17A, TLR2, TLR4). The data obtained demonstrate the high diagnostic value of a comprehensive approach incorporating immunogenetic markers.

Keywords: reactive arthritis, urogenital infection, chlamydia, HLA-B27, IL-17, TLR

First page

29

Last page

34

For citation:Pulatov U.S., Shopulotov Sh.A. - DIAGNOSTIC FEATURES OF REACTIVE ARTHRITIS OF UROGENITAL ETIOLOGY//New Day in Medicine 2(88)2026 29-34 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Ameen J., Moorthy A. Reactive arthritis: a clinical review // Journal of the Royal College of Physicians of Edinburgh. 2021;51(3):288-297.
  2. BASHH. British Association for Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis (SARA) // International Journal of STD AIDS. 2021;32(11):986-997.
  3. Carter J.D., Hudson A.P. Reactive arthritis: clinical aspects and medical management // Rheumatic Disease Clinics of North America. 2021;47(3):489-504.
  4. Ding Y., Wang L., Li T. et al. Clinical characteristics of reactive arthritis with and without HLA-B27: a retrospective study // Medicine (Baltimore). 2022;101(35):303-83.
  5. European Centre for Disease Prevention and Control. Chlamydia control in Europe – surveillance and diagnostic challenges. – Stockholm, 2022.
  6. Kuipers J.G., Rihl M. Reactive arthritis: diagnostic challenges and current concepts // Zeitschrift für Rheumatologie. 2025;84(4):259-267.
  7. StatPearls Publishing. Reactive Arthritis // StatPearls [Internet]. – Treasure Island (FL), 2025.
  8. Tam L.S., Li E.K. Th17 pathway in spondyloarthritis and reactive arthritis // Current Rheumatology Reports. 2021;23(6):38-45.
  9. Tukaj S., Kotlarz A. Toll-like receptors in inflammatory arthritis // International Journal of Molecular Sciences. 2020;21(18):1-18.
  10. The Rheumatologist. Reactive arthritis: chronic or self-limiting disease? – 2024.
  11. Пулатов У.С., Шопулотов Ш.А. Реактивный артрит урогенитальной этиологии // Проблемы биологии и медицины 2025;5(165):347-350
  12. Pulatov U., Shopulotov S. Urogenital etiologiyali reaktiv artritini tashxislash istiqbollari // South aral sea medical journal. 2025;1(X):275-279.

    file

    download